SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001214659-24-001920
Filing Date
2024-02-05
Accepted
2024-02-05 16:01:21
Documents
1
Group Members
OCTAGON INVESTMENTS MASTER FUND LPTING JIA

Document Format Files

Seq Description Document Type Size
1 j15240sc13g.htm SC 13G 65220
  Complete submission text file 0001214659-24-001920.txt   66900
Mailing Address 18575 JAMBOREE ROAD SUITE 275-S IRVINE CA 92612
Business Address 18575 JAMBOREE ROAD SUITE 275-S IRVINE CA 92612 (858) 283-0280
Reneo Pharmaceuticals, Inc. (Subject) CIK: 0001637715 (see all company filings)

IRS No.: 472309515 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-92480 | Film No.: 24595638
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 654 MADISON AVENUE 21ST FLOOR NEW YORK NY 10065
Business Address 654 MADISON AVENUE 21ST FLOOR NEW YORK NY 10065 212-369-2829
Octagon Capital Advisors LP (Filed by) CIK: 0001839435 (see all company filings)

IRS No.: 843576791 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G